SCIENTIFIC PROGRAMME
Preliminary Programme
PLENARIES
CONFIRMED SPEAKER | TITLE |
Meenhard Herlyn (Philadelphia, USA) | Molecular Understanding of Therapy Resistance in Melanoma |
Julia Newton-Bishop (Leeds, UK) | Melanoma Genetics |
Boris Bastian (San Fransisco, USA) | Genetic and Phenotypic Alterations Melanoma |
Michael Detmar (Zurich, Switzerland) | Angiogenesis and Lymphangiogenesis in Melanoma |
Jan Bouwes-Bavinck (Leiden, Netherlands) | Skin Cancer in the Immunosuppressed Patient |
Hensin Tsao (Boston, USA) | Update on Melanoma Genetics |
Alain Spatz (Villejuif, France) | Prognostic Markers |
Keith T. Flaherty (Philadelphia, USA) | Targeted Therapy |
Claus Garbe (Tübingen, Germany) | Adjuvant Therapy |
Vernon Sondak (Tampa, USA) | Sentinel Lymph Node |
Caroline Robert (Villejuif, France) | Cutaneous Side Effects of New Drugs |
Axel Hauschild (Kiel, Germany) | New Studies in Melanoma Therapy |
SYMPOSIA TOPICS
CONFIRMED SPEAKER | TITLE |
Jean-Jacques Grob (Marsaille, France) | Primary Prevention and Public Education |
Michael Binder (Vienna, Austria) | Early Recognition: Screening and Dermoscopy |
Claus Garbe (Tübingen, Germany) | Management of Melanocytic Nevi |
Julia Newton-Bishop (Leeds, UK) | Genetics |
Martin C. Mihm (Boston, USA) | Pathology: Established and Evolving Concepts |
Mario Santinami (Milano, Italy) | Surgery |
Merrick Ross (Houston, USA) | Sentinel Lymphnode – Pros and Cons |
Paul Lorigan (Manchester, UK) | Targeted Therapy |
Michael Detmar (Zurich, Switzerland) | Angiogenesis and Lymphangiogenesis |
Jürgen Becker (Würzburg, Germany) | Gene Expression and Proteome Analysis |
Meenhard Herlyn (Philadelphia, USA) | Signaling Cascades |
Martin Gore (London, UK) | Chemotherapies: Which, When and Why? |
Anthony Ribas (Los Angeles, USA) | Melanoma Antibody Revival |
Thomas Schwarz (Kiel, Germany) | Photocarcinogenesis and Sun Protection |
Michael Musalek (Vienna, Austria) | Psychodermato-Oncology |
Hans Peter Soyer (Queensland, Australia) | Teledermato-Oncology |
Robert Knobler (Vienna, Austria) | Lymphoma |
Dirk Schadendorf (Mannheim, Germany) | Vaccination |
John F. Thompson (Sydney, Australia), | Melanoma Centers |
Marianne Berwick (Albuquerque, USA) | Melanoma-Epidemiology |
Markus H. Frank (Boston, USA) | Melanoma Stem Cells |
John M. Kirkwood (Pittsburgh, USA) | Inteferon (who should receive interferon, how much and how long) |
Rolf Markus Szeimies (Regensburg, Germany) | Photodynamic Therapy |
Alexander Stratigos (Athens, Greece) | Non Melanoma Skin Cancer I – |
Eggert Stockfleth (Berlin, Germany) | Non Melanoma Skin Cancer II – |
Jason Rivers (Vancouver, Canada) | Non Melanoma Skin Cancer III – |
Jürgen Becker (Würzburg, Germany) | Rare Skin Tumors |
Ash Marghoob (New York, USA) | New Diagnostic Tools |
Michael Binder (Vienna, Austria) | Course on Dermoscopy |

Printversion